MDQK.HM stock led today’s high-volume movers on the HAM session after a dramatic intraday move to €7.50, up 200.00% from the previous close of €2.50 on 06 Mar 2026. The spike came on very low absolute volume — 35.00 shares vs an average of 41.00 — which suggests price action driven by concentrated orders rather than broad buying. Traders should treat the move as volatile, not structural, given no public earnings release and limited market liquidity for MediNavi AG on the Hamburg exchange (HAM). We use data-driven context and Meyka AI’s market tools to explain what this means for short-term traders and longer-term investors.

MDQK.HM stock intraday move and volume

MediNavi AG (MDQK.HM) opened at €2.50 and recorded a day low of €2.50 and a day high of €7.50, producing a €5.00 intraday change equal to 200.00% on 06 Mar 2026; volume was 35.00 versus an average volume of 41.00, indicating a concentrated trade rather than market-wide participation.

MDQK.HM news and likely catalysts

There is no official earnings announcement or press release tied to this spike and the company’s public profile lists its platform and IPO date (2018-09-27); the price move appears driven by microcap liquidity and order flow, not a visible fundamental event, so confirm any news on the company website before trading source.

Valuation, financials and key ratios for MDQK.HM stock

MediNavi shows no published EPS or PE ratio and enterprise value is negative at -€255031.00, while EV/EBITDA is 2.17, current ratio is 41.50, and interest coverage is -1362.59, a mix that points to odd accounting items and thin trading but not typical operational scale found across Healthcare sector peers.

Meyka AI rates MDQK.HM with a score out of 100

Meyka AI rates MDQK.HM with a score out of 100: 62.58 (Grade: B, Suggestion: HOLD). This score factors S&P 500 comparison, sector and industry performance, financial growth, key metrics and analyst signals and is meant as a data-driven summary rather than investment advice.

Technical picture and trading risks

Short-term technicals show the stock trading well above the 50-day and 200-day averages at €2.50 and €2.00 respectively, while ATR is 5.00, signalling extreme intraday volatility; low liquidity and a relative volume below 1.00 mean order imbalances can produce outsized moves and execution risk for large orders.

Price scenarios and MDQK.HM forecast

Analyst-style scenario planning gives a conservative bear target of €2.00 (implied downside -73.33%), a base target of €5.00 (implied downside -33.33%), and a bull target of €12.00 (implied upside 60.00%) compared with the current price of €7.50; these are scenario outputs for planning, not formal consensus figures.

Final Thoughts

Key takeaway: MDQK.HM stock traded as a high-volume mover in name but on very limited liquidity, pushing the price to €7.50 on 06 Mar 2026 with a 200.00% intraday change that likely reflects concentrated order flow rather than broad fundamental news. Meyka AI’s forecast model projects a base-case near €5.00, implying an approximate -33.33% downside from the current price; alternative scenarios range down to €2.00 or up to €12.00, underscoring high volatility. Investors should treat intraday spikes in thinly traded Healthcare microcaps like MediNavi AG (MDQK.HM) on HAM with caution, verify any company disclosure at the source, and consider execution risk and tight spreads before initiating positions. Meyka AI provides this data-driven market analysis through its AI-powered market analysis platform, but these forecasts are model-based projections and not guarantees of future performance.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.